MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
April 18, 2008
Brian Orelli
Recalls Can't Beat Baxter In spite of charges for two recalls, Baxter posts a decent quarter. mark for My Articles similar articles
The Motley Fool
April 10, 2008
Brian Orelli
The News for Baxter Just Got Worse These heparin-related deaths aren't associated with Baxter's product, but they still might spell trouble for the company. mark for My Articles similar articles
The Motley Fool
July 20, 2007
Brian Orelli
Baxter's Mixed Message A recall of Baxter BioScience's COLLEAGUE infusion pumps seems to have over-shadowed healthy quarterly earnings reports. mark for My Articles similar articles
The Motley Fool
March 10, 2008
Brian Orelli
Breakup Weighs Down APP It's going to take awhile for APP Pharmaceuticals to reward investors. mark for My Articles similar articles
The Motley Fool
September 27, 2007
Billy Fisher
Baxter Looking to Bounce Back Shares of the medical device maker finally rebound following a company recall of infusion pumps. mark for My Articles similar articles
Food Engineering
February 11, 2009
FDA releases recall tool: Try it out! FDA's recall tool provides up-to-date info on Salmonella recalls mark for My Articles similar articles
The Motley Fool
February 21, 2008
Brian Lawler
A Bit of Irony From the FDA The agency has a mixed message on drug importation, as evidenced in the recent possible contamination of China-produced Heparin. mark for My Articles similar articles
The Motley Fool
September 24, 2008
Brian Orelli
Hey, You! Stop! The FDA has ordered Baxter and Hospira to stop making their ophthalmic balanced salt solutions within 60 days. mark for My Articles similar articles
The Motley Fool
March 7, 2008
Brian Lawler
A Little Too Much Drug Variability Another drugmaker has to recall batches of its compound. mark for My Articles similar articles
Food Engineering
April 14, 2009
FDA releases pistachio recall widget This device works similarly to the recent PCA peanut paste FDA product recall list. mark for My Articles similar articles
The Motley Fool
April 20, 2006
Stephen D. Simpson
Baxter Bags Better Margins This is a great business -- but only at the right price. Investors, this story has to be bought cheap. At today's prices, is it cheap enough? mark for My Articles similar articles
The Motley Fool
October 19, 2007
Brian Orelli
Baxter Gets Pumped Up Medical-device maker Baxter puts in a nice quarter despite two recent FDA recalls. mark for My Articles similar articles
The Motley Fool
July 9, 2010
Brian Orelli
Hey, Johnson & Johnson: Eight Is Enough If Johnson & Johnson can't overcome the negative image from recalls quickly, consumers will head to competing brand-name drugs or just grab generic versions of Johnson & Johnson's products. mark for My Articles similar articles
Food Processing
March 2008
David Joy
Pros and cons of food recall authority While it may be inevitable that Congress will grant FDA food recall authority, there are reasons why this may not have a good impact on food safety. mark for My Articles similar articles
The Motley Fool
March 31, 2008
Brian Lawler
FDA Commish Joins Blogosphere Andrew von Eschenbach, the FDA's chief, starts a weekly blog. mark for My Articles similar articles
The Motley Fool
March 16, 2010
Brian Orelli
No Matter What You Call It, It Still Stinks A recall over a paperwork issue? What have you guys been doing? Announcing a recall of your heart defibrillators during a major cardiology meeting probably isn't the best move mark for My Articles similar articles
The Motley Fool
July 8, 2008
Brian Orelli
Now That's the Way to Spin Off a Company The two spin-off companies formed from Abraxis Pharmaceutical, APP Pharmaceuticals and Abraxis BioScience, are worth almost double the value their parent had before the sale. mark for My Articles similar articles
Food Engineering
April 1, 2008
Richard F. Stier
Recalls are a fact of life Does more recalls mean our food supply is becoming more dangerous, or that our regulators are doing their job and protecting the public health? Or does it mean something completely different? mark for My Articles similar articles
The Motley Fool
October 16, 2009
Robert Steyer
Baxter Beats Again -- the Streak Is Alive! The drug, device, and medical services giant beats Wall Street earnings estimates by a penny, but flat sales signal caution. mark for My Articles similar articles
The Motley Fool
May 31, 2007
Billy Fisher
Not Seeing 20/20 at Advanced Medical Optics The company recalls a contact lens solution that might be linked to a rare infection. Investors, take note. mark for My Articles similar articles
The Motley Fool
May 6, 2010
Brian Orelli
Johnson & Johnson, What Have You Done? We're not sure, but Congress wants to find out. The House Committee on Oversight and Government Reform launched an investigation yesterday into the recall JNJ announced last week. mark for My Articles similar articles
The Motley Fool
April 2, 2008
Brian Lawler
Medicines Company Sets Itself Apart Drugmaker Medicines Company wants to distance its angioplasty treatment from heparin. mark for My Articles similar articles
Food Processing
November 2007
David Joy
Regulatory Issues: New rules on reporting contamination Manufacturers will not have the option of handing recalls quietly. Information may even appear on FDA's web site. mark for My Articles similar articles
The Motley Fool
June 17, 2010
Claire Stephanic
More Recall Troubles for Johnson & Johnson Its McNeil Consumer Healthcare division expands its recall on Tylenol and Motrin products. mark for My Articles similar articles
The Motley Fool
August 26, 2008
Brian Orelli
Baxter Ready to Sop Up Additional Revenue The health-care giant licenses a surgical sponge in clinical development. mark for My Articles similar articles
InternetNews
August 24, 2006
David Needle
Apple Recalls A Million Batteries Apple Computer is the latest to announce recall of Sony batteries in its notebooks. mark for My Articles similar articles
The Motley Fool
January 28, 2005
Brian Gorman
Baxter Plods On 2005 looks like another year of transition for Baxter International. The medical products and services concern reported that after currency adjustments, fourth-quarter 2004 revenue of $2.6 billion was essentially flat compared with the same period in 2003. mark for My Articles similar articles
The Motley Fool
April 17, 2009
Robert Steyer
The Steady BAX Beat Baxter International's diverse medical offerings continue to produce prosperity. mark for My Articles similar articles
Food Processing
August 2011
Kronenberg & Renfro
Food Processors: Are You Prepared for a Recall? Tips from a food processor who went through one. mark for My Articles similar articles
The Motley Fool
October 21, 2010
Rich Smith
Picture of the Day: Toyota -- Moving Backward Citing a range of problems newly discovered -- problems with fuel pumps, problems with the brake fluid -- Toyota this morning announced it must recall 740,000 Lexus, Avalon, and Highlander models in the U.S. mark for My Articles similar articles
The Motley Fool
September 8, 2008
Rich Duprey
The Coming Great Pharma Panic The FDA's drug warning list provides dangerously little information. mark for My Articles similar articles
InternetNews
May 24, 2010
More HP Laptop Batteries Recalled The company has to expand its recall to another 54,000 batteries because they are at risk of catching fire. Is yours on the list? mark for My Articles similar articles
The Motley Fool
July 1, 2004
Rich Smith
Honda's Signals Mixed Honda's reputation for reliability will almost certainly suffer when the recall for more than 1.1 million Accords, Acuras, Odyssey minivans, and Pilot and Acura SUVs is announced. mark for My Articles similar articles
IndustryWeek
February 1, 2007
Traci Purdum
Do You Recall? If you manufacture a product - any product - chances are good you may have a product recall in your future. Implementing best practices during a recall will help ensure consumer safety and company longevity. mark for My Articles similar articles
Food Processing
February 2011
David Joy
7 Things You Should Know About The New Food Safety Law Considered a win for consumers, the new law will have varying effects on food & beverage processors. mark for My Articles similar articles
U.S. CPSC
January 11, 2010
CPSC Approves Final Rule on Guidelines for Mandatory Recall Notices The U.S. Consumer Product Safety Commission unanimously approved a new rule setting guidelines and requirements for information in mandatory recall notices. mark for My Articles similar articles
Food Engineering
May 1, 2008
Richard F. Stier
Are you truly prepared for a crisis? Because few recalls or crises occur during a normal workday when all staff is available, every processor should mandate several levels of staffing backup for managing recalls. mark for My Articles similar articles
The Motley Fool
April 22, 2005
Brian Gorman
Baxter Is on the Mend The medical products company continues to right itself for a brighter future. The firm's long-term positioning and diversified business may make it worth a closer look. mark for My Articles similar articles
The Motley Fool
November 3, 2011
Dan Caplinger
Has Baxter International Become the Perfect Stock? Baxter needs to keep working on getting its debt levels down and seek out new growth opportunities. With favorable demographic winds at its back, Baxter could be the rare stock to actually reach perfection. mark for My Articles similar articles
The Motley Fool
September 12, 2007
Brian Orelli
Fitting Fission at Abraxis BioScience Abraxis BioScience will split itself into a biotech firm and a generic drug business. Both new companies stand to benefit, but will investors? mark for My Articles similar articles
The Motley Fool
November 12, 2007
Brian Orelli
Valuing a Breakup Abraxis makes its final earnings report before it becomes two companies. Its hospital-based products division will hereafter be known as APP Pharmaceuticals. mark for My Articles similar articles
IndustryWeek
September 14, 2011
Are You Prepared for a Product Recall? Experts urge manufacturers to be proactive as costs, scrutiny of recalls continue to escalate. mark for My Articles similar articles
The Motley Fool
July 6, 2007
Brian Orelli
Breaking Up Is Easy to Do Drugmaker Abraxis splits in two. It will be a few years before investors know whether the breakup was beneficial to the new companies. mark for My Articles similar articles
Food Processing
September 2010
Cracks in Our Food Safety Systems A 3-Part Series on one of the most important topics facing food processors today: Food Safety. mark for My Articles similar articles
Chemistry World
August 19, 2008
Ananyo Bhattacharya
Flask synthesis promises untainted heparin US researchers have created milligrams of pure heparin using enzymes and chemicals - a practical laboratory synthesis that could avoid the contamination issues surrounding the blood-thinning drug mark for My Articles similar articles
The Motley Fool
March 10, 2008
Brian Orelli
A Drug to Wake Up Schering Bridion gets an FDA panel review. mark for My Articles similar articles
The Motley Fool
October 7, 2010
Rich Smith
Welcome to the Big Leagues, Tesla Congratulations, parents. It's a recall! mark for My Articles similar articles
Chemistry World
August 7, 2015
Suzanne Howson
Simple probe for heparin quality control Scientists in China have developed a fluorescent probe to detect both heparin and its major contaminant. The sensor could make it easier to monitor the quality of heparin supplies. mark for My Articles similar articles
Registered Rep.
June 14, 2007
Kevin Burke
Pilgrim Baxter's Payback The SEC announced this week that it is returning ill-gotten gains to Pilgrim Baxter (investment advisor to the PBHG fund family) shareholders, three and half years after the fund company was engulfed in a trading scandal. mark for My Articles similar articles
AskMen.com
November 21, 2003
Paul Anderson
How Do Car Recalls Work? With 1,450 recalls and alerts released in the U.S. in 2002, cases of dangerous malfunctions have become far too common. Keeping that in mind, here are the details of a car recall in an easy-to-comprehend question-and-answer session. mark for My Articles similar articles